Large-scale, multi-centre, multi-disease validation of an AI clinical
  tool for cine CMR analysis
  INTRODUCTION: Artificial intelligence (AI) has the potential to facilitate
the automation of CMR analysis for biomarker extraction. However, most AI
algorithms are trained on a specific input domain (e.g., single scanner vendor
or hospital-tailored imaging protocol) and lack the robustness to perform
optimally when applied to CMR data from other input domains. METHODS: Our
proposed framework consists of an AI-based algorithm for biventricular
segmentation of short-axis images, followed by a post-analysis quality control
to detect erroneous results. The segmentation algorithm was trained on a large
dataset of clinical CMR scans from two NHS hospitals (n=2793) and validated on
additional cases from this dataset (n=441) and on five external datasets
(n=6808). The validation data included CMR scans of patients with a range of
diseases acquired at 12 different centres using CMR scanners from all major
vendors. RESULTS: Our method yielded median Dice scores over 87%, translating
into median absolute errors in cardiac biomarkers within the range of
inter-observer variability: <8.4mL (left ventricle), <9.2mL (right ventricle),
<13.3g (left ventricular mass), and <5.9% (ejection fraction) across all
datasets. Stratification of cases according to phenotypes of cardiac disease
and scanner vendors showed good agreement. CONCLUSIONS: We show that our
proposed tool, which combines a state-of-the-art AI algorithm trained on a
large-scale multi-domain CMR dataset with a post-analysis quality control,
allows us to robustly deal with routine clinical data from multiple centres,
vendors, and cardiac diseases. This is a fundamental step for the clinical
translation of AI algorithms. Moreover, our method yields a range of additional
biomarkers of cardiac function (filling and ejection rates, regional wall
motion, and strain) at no extra computational cost.
